(28) report that under hypoxic conditions, CDK4/6 inhibition with agents like palbociclib not only blocks cell proliferation but also reduces HIF1α accumulation, enhancing cancer cell sensitivity to apoptotic signals. This evidence concerns the gene CDK4 and cancer.